Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Experimental and Applied Biomedical Research (EABR)
Volume 18 (2017): Issue 3 (October 2017)
Open Access
Higher Serum Uric Acid Levels in Multiple Sclerosis Patients After Longterm Interferon Beta Treatment
Gordana Toncev
Gordana Toncev
,
Katarina Vesic
Katarina Vesic
,
Dejan Aleksic
Dejan Aleksic
and
Snežana Lazarevic
Snežana Lazarevic
| Oct 19, 2017
Experimental and Applied Biomedical Research (EABR)
Volume 18 (2017): Issue 3 (October 2017)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Oct 19, 2017
Page range:
227 - 230
Received:
May 05, 2016
Accepted:
Jul 05, 2016
DOI:
https://doi.org/10.1515/sjecr-2016-0052
Keywords
multiple sclerosis
,
interferon beta
,
uric acid
© 2017
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Gordana Toncev
Clinic of neurology, Clinical Center
Kragujevac, Serbia
Faculty of Medical Sciences, University of Kragujevac,
Kragujevac, Serbia
Katarina Vesic
Faculty of Medical Sciences, University of Kragujevac,
Kragujevac, Serbia
Dejan Aleksic
Faculty of Medical Sciences, University of Kragujevac,
Kragujevac, Serbia
Snežana Lazarevic
Faculty of Medical Sciences, University of Kragujevac,
Kragujevac, Serbia